(Q83189240)
Statements
Clinical trial: a multicentre, randomized, double-blind, placebo-controlled, dose-finding, phase II study of subcutaneous interferon-beta-la in moderately active ulcerative colitis (English)
C Pena-Rossi
S Schreiber
G Golubovic
A Mertz-Nielsen
D Rachmilewitz
M J Shieh
V I Simanenkov
D Stanton
1 September 2008